Total raised
—
Stage
Pre-Funding
Founded
2016
Headcount
6
HQ
Haifa
Sector
Health Tech & Life Sciences
About
IOIV is a novel additive solution for extending the shelf life of packed red blood cells, while preserving their quality. The product is easy to use, minimizes the wastage of expired blood donations and maximizes the quality of transfused blood. IOIV combines both profitable and lifesaving concepts in one improved and simple product.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is IOIV's primary business focus?
- IOIV is focused on developing a novel additive solution designed to extend the shelf life of packed red blood cells while maintaining their quality.
- When was IOIV founded?
- IOIV was founded in January 2016.
- What is the current operational status of IOIV?
- IOIV has been inactive since September 2018.
- Where is IOIV headquartered?
- IOIV is headquartered in Haifa, Israel.
- How many employees did IOIV have?
- IOIV had between 1 and 10 employees.
- What is IOIV's current funding stage?
- IOIV is currently in the Pre-Funding stage.
- Has IOIV raised any funding?
- According to startupim data, IOIV has not raised any funding.
- Who are the founders of IOIV?
- The founders of IOIV are Tom Givaty Katz, Tal Ofek, Rawan Omar, and Sofia Arshavsky-Graham.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesHealthcareProvidersMedical Devices IndustryMedical Products
Business model
B2B
Tags
stealthmodepharmaceuticalsmedical-products